ImmunoGen is a biotechnology company that develops antibody-drug conjugate therapies for treating cancer. Its product candidates include mirvetuximab soravtansine for ovarian cancer and Pivekimab sunirine for acute myeloid leukemia. The company has collaborations with leading organizations in the field, such as Roche, Amgen, and Novartis.